The association of clinical follow-up intervals in HIV-Infected persons with viral suppression on subsequent viral suppression

AIDS Patient Care and STDs

Volumn 27, Issue 8, 2013, Pages 459-466

  Buscher, April ^a,j   Mugavero, Michael ^b   Westfall, Andrew O ^b   Keruly, Jeanne ^c   Moore, Richard ^c   Drainoni, Mari Lynn ^d,e   Sullivan, Meg ^e   Wilson, Tracey E ^f   Rodriguez, Allan ^g   Metsch, Lisa ^g,k   Gardner, Lytt ^h   Marks, Gary ^h   Malitz, Faye ⁱ   Giordano, Thomas P ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^e BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f SUNY DOWNSTATE MEDICAL CENTER   (United States)

^g UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^h CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

ⁱ HEALTH RESOURCES AND SERVICES ADMINISTRATION   (United States)

^j DURHAM VA MEDICAL CENTER   (United States)

^k Department of Medicine   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; FEMALE; FOLLOW UP; HETEROSEXUALITY; HISPANIC; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MAJOR CLINICAL STUDY; MALE; MEDICAID; MEDICARE; MEN WHO HAVE SEX WITH MEN; PRIVATE HEALTH INSURANCE; RETROSPECTIVE STUDY; VIRUS LOAD;

ADULT; ANTI-HIV AGENTS; APPOINTMENTS AND SCHEDULES; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; MALE; MULTIVARIATE ANALYSIS; OFFICE VISITS; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; VIRAL LOAD; YOUNG ADULT;

EID: 84883142838     PISSN: 10872914     EISSN: 15577449     Source Type: Journal    
DOI: 10.1089/apc.2013.0105     Document Type: Article

References (27)

1. Rodger AJ, Lodwick R, Schechter M, et al. Mortality in well controlled HIV in the continuous antiretroviral therapy arms of the SMART and ESPRIT trials compared with the general population. AIDS 2013;27:973-979.
2. Reekie J, Mocroft A, Sambatakou H, et al. Does less frequent routine monitoring of patients on a stable, fully suppressed cART regimen lead to an increased risk of treatment failure- AIDS 2008;22:2381-2390.
3. Romih V, Zidovec LS, Gedike K, Lukas D, Begovac J. Frequency of HIV-1 viral load monitoring of patients initially successfully treated with combination antiretroviral therapy. PLoS One 2010;5:e15051.
4. Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. http://www.aidsinfo.nih.gov/ contentfiles/lvguidelines/adultandadolescentgl.pdf. Accessed on July 19, 2013.
5. Marks G, Gardner LI, Craw J, Crepaz N. Entry and retention in medical care among HIV-diagnosed persons: A metaanalysis. AIDS 2010;24:2665-2678.
6. Mugavero MJ, Lin HY, Allison JJ, et al. Failure to establish HIV care: characterizing the no show phenomenon. Clin Infect Dis 2007;45:127-130.
7. Giordano TP, Visnegarwala F, White AC, Jr., et al. Patients referred to an urban HIV clinic frequently fail to establish care: Factors predicting failure. AIDS Care 2005;17:773-783.
8. Liang K, Zeger S. Longitudinal data analysis using generalized linear models. Biometrika 1986;73:13-22.
9. Ibrahim K, Recordon-Pinson P, Malvy D, Fleury H, Segurado AC. Intermittent HIV-1 viremia (blipids) and virological failure in a cohort of people living with HIV from Sa?o Paulo, Brazil. AIDS Patient Care STDS 2012;26;512-515.
10. Magnus M, Herwehe J, Murtaza-Rossini M, et al. Linking and retaining HIV patients in care: The importance of provider attitudes and behavior. AIDS Patient Care STDS 2013;27:297-303.
11. Graham JL, Giordano TP, Grimes RM, Slomka J, Ross M, Hwang LY. Influence of trust on HIV diagnosis and care practices: A literature review. J Int Assoc Physicians AIDS Care (Chic) 2010;9:346-352.
12. Roberts RR, Kampe LM, Hammerman M, et al. The cost of care for patients with HIV from the provider economic perspective. AIDS Patient Care STDS 2006;20:876-886.
13. Schackman BR, Gebo KA, Walensky RP, et al. The lifetime cost of current human immunodeficiency virus care in the United States. Med Care 2006;44:990-997.
14. Lucas GM, Chaisson RE, Moore RD. Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions. Ann Intern Med 1999;131:81-87.
15. Mugavero MJ, Lin HY, Allison JJ, et al. Racial disparities in HIV virologic failure: do missed visits matter- J Acquir Immune Defic Syndr 2009;50:100-108.
16. Giordano TP, Gifford AL, White AC, Jr., et al. Retention in care: A challenge to survival with HIV infection. Clin Infect Dis 2007;44:1493-1499.
17. Giordano TP, Hartman C, Gifford AL, Backus LI, Morgan RO. Predictors of retention in HIV care among a national cohort of US veterans. HIV Clinical Trials 2009;10:299-305.
18. Perez-Molina JA, az-Menendez M, Plana MN, Zamora J, Lopez-Velez R, Moreno S. Very late initiation of HAART impairs treatment response at 48 and 96 weeks: results from a meta-analysis of randomized clinical trials. J Antimicrob Chemother 2012;67:312-321.
19. Abgrall S, Duval X, Joly V, Descamps D, Matheron S, Costagliola D. Clinical and immunologic outcome in patients with human immunodeficiency virus infection, according to virologic efficacy in the year after virus undetectability, during antiretroviral therapy. Clin Infect Dis 2003;37:1517-1526.
20. Paredes R, Mocroft A, Kirk O, et al. Predictors of virological success and ensuing failure in HIV-positive patients starting highly active antiretroviral therapy in Europe: results from the EuroSIDA study. Arch Intern Med 2000;160:1123-1132.
21. Robbins GK, Daniels B, Zheng H, Chueh H, Meigs JB, Freedberg KA. Predictors of antiretroviral treatment failure in an urban HIV clinic. J Acquir Immune Defic Syndr 2007;44:30-37.
22. Taiwo BO, Li X, Palella F, et al. Higher risk of AIDS or death in patients with lower CD4 cell counts after virally suppressive HAART. HIV Med 2009;10:657-660.
23. Robison LS, Westfall AO, Mugavero MJ, et al. Short-term discontinuation of HAART regimens more common in vulnerable patient populations. AIDS Res Human Retroviruses 2008;24:1347-1355.
24. Shapiro MF, Morton SC, McCaffrey DF, et al. Variations in the care of HIV-infected adults in the United States: results from the HIV Cost and Services Utilization Study. JAMA 1999;281:2305-2315.
25. Mugavero MJ, Lin HY, Willig JH, et al. Missed visits and mortality among patients establishing initial outpatient HIV treatment. Clin Infect Dis 2009;48:248-256.
26. Das M, Chu PL, Santos GM, et al. Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco. PLoS One 2010;5:e11068.
27. Palella FJ, Baker RK, Buchacz K, et al. Increased mortality amoung publicly insured participants in the HIV Outpatient Study despite HAART treatment. AIDS 2011;25: 1865-1876.